Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study

References

• Ahmad, S., Chitkara, P., Khan, F. N., Kishan, A., Alok, V., Ramlal, A., & Mehta, S. (2021). Mobile technology solution for COVID-19: surveillance and prevention. In Computational intelligence methods in COVID-19: Surveillance, prevention, prediction and diagnosis (pp. 79–108). Springer.
   Google Scholar
• Banks, J., Beard, H., Cao, Y., Cho, A., Damm, W., Farid, R., Felts, A., Halgren, T., Mainz, D., Maple, J., Murphy, R., Philipp, D., Repasky, M., Zhang, L., Berne, B., Friesner, R., Gallicchio, E., & Levy, R. (2005). Integrated modeling program, applied chemical theory (IMPACT). Journal of Computational Chemistry, 26(16), 1752–1780.
   PubMed Web of Science ®Google Scholar
• Basu, A. (2020). Estimating the infection fatality rate among symptomatic COVID-19 cases in the United States: Study estimates the COVID-19 infection fatality rate at the US county level. Health Affairs (Project Hope), 39(7), 1229–1236. https://doi.org/10.1377/hlthaff.2020.00455
   PubMed Web of Science ®Google Scholar
• Bose, P., Simmons, G. L., & Grant, S. (2013). Cyclin-dependent kinase inhibitor therapy for hematologic malignancies. Expert Opinion on Investigational Drugs, 22(6), 723–738.
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., & Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters [Paper presentation]. SC’06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, (Ed.).
   Google Scholar
• Durdagi, S. (2020). Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target. Turkish Journal of Biology, 44(SI-1), 185–191.
   PubMedGoogle Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (2009). Identifying and characterizing binding sites and assessing druggability. Journal of Chemical Information and Modeling, 49(2), 377–389. https://doi.org/10.1021/ci800324m
   PubMed Web of Science ®Google Scholar
• Huang, C., Li, C., Choi, P. Y., Nandakumar, K., & Kostiuk, L. W. (2011). A novel method for molecular dynamics simulation in the isothermal–isobaric ensemble. Molecular Physics, 109(2), 191–202. https://doi.org/10.1080/00268976.2010.513345
   Web of Science ®Google Scholar
• Ioakimidis, L., Thoukydidis, L., Mirza, A., Naeem, S., & Reynisson, J. (2008). Benchmarking the reliability of QikProp. Correlation between experimental and predicted values. QSAR & Combinatorial Science, 27(4), 445–456. https://doi.org/10.1002/qsar.200730051
   Google Scholar
• Ioannidis, J. P. (2020). Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic. European Journal of Clinical Investigation, 50(12), e13423. https://doi.org/10.1111/eci.13423
   PubMed Web of Science ®Google Scholar
• Kadioglu, O., Saeed, M., Greten, H. J., & Efferth, T. (2021). Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Computers in Biology and Medicine, 133, 104359.
   PubMed Web of Science ®Google Scholar
• Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020). The architecture of SARS-CoV-2 transcriptome. Cell, 181(4), 914–921.e910.
   PubMed Web of Science ®Google Scholar
• Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins: Structure, Function, and Bioinformatics, 79(10), 2794–2812. https://doi.org/10.1002/prot.23106
   PubMed Web of Science ®Google Scholar
• Martin, M., Olesen, S., Georg, G., & Schönbrunn, E. (2013). Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains. ACS Chemical Biology, 8(11), 2360–2365.
   PubMed Web of Science ®Google Scholar
• Mita, M., Joy, A., Mita, A., Sankhala, K., Jou, Y.-M., Zhang, D., Statkevich, P., Zhu, Y., Yao, S.-L., Small, K., Bannerji, R., & Shapiro, C. (2014). Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer. Clinical Breast Cancer, 14(3), 169–176.
   PubMed Web of Science ®Google Scholar
• Nguyen, T. K., & Grant, S. (2014). Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1-and 5-dependent mechanism. Molecular Cancer Therapeutics, 13(3), 662–674.
   PubMed Web of Science ®Google Scholar
• Osipiuk, J., Jedrzejczak, R., Tesar, C., Endres, M., Stols, L., Babnigg, G., Kim, Y., Michalska, K., & Joachimiak, A. (2020). The crystal structure of papain-like protease of SARS CoV-2. RSCB PDB.
   Google Scholar
• Pal, M., Berhanu, G., Desalegn, C., & Kandi, V. (2020). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus, 12(3) https://doi.org/10.7759/cureus.7423
   Web of Science ®Google Scholar
• Parry, D., Guzi, T., Shanahan, F., Davis, N., Prabhavalkar, D., Wiswell, D., Seghezzi, W., Paruch, K., Dwyer, M., Doll, R., Nomeir, A., Windsor, W., Fischmann, T., Wang, Y., Oft, M., Chen, T., Kirschmeier, P., & Lees, E. (2010). Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor. Molecular Cancer Therapeutics, 9(8), 2344–2353.
   PubMed Web of Science ®Google Scholar
• QikProp. (2017). Schrödinger Release 2017-1: QikProp. Schrödinger, LLC.
   Google Scholar
• Release, S. (2017). 2: LigPrep., Schrödinger, LLC.
   Google Scholar
• Rizou, M., Galanakis, I. M., Aldawoud, T. M., & Galanakis, C. M. (2020). Safety of foods, food supply chain and environment within the COVID-19 pandemic. Trends in Food Science & Technology, 102, 293–299. https://doi.org/10.1016/j.tifs.2020.06.008
   PubMed Web of Science ®Google Scholar
• Satyam, R., Yousef, M., Qazi, S., Bhat, A. M., & Raza, K. (2021). COVIDium: A COVID-19 resource compendium. Database, 2021. https://doi.org/10.1093/database/baab057
   Google Scholar
• Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: a software program for pK a prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681–691. https://doi.org/10.1007/s10822-007-9133-z
   PubMed Web of Science ®Google Scholar
• Sohrabi, C., Alsafi, Z., O’neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery (London, England), 76, 71–76. https://doi.org/10.1016/j.ijsu.2020.02.034
   PubMed Web of Science ®Google Scholar
• Struyf, T., Deeks, J., Dinnes, J., Takwoingi, Y., Davenport, C., Leeflang, M., Spijker, R., Hooft, L., Emperador, D., Domen, J., Horn, S., & Van den Bruel, A. (2021). Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19. Cochrane Database of Systematic Reviews, 2021(3). https://doi.org/10.1002/14651858.CD013665.pub2
   Google Scholar
• Tang, S., Mao, Y., Jones, R., Tan, Q., Ji, J., Li, N., Shen, J., Lv, Y., Pan, L., Ding, P., Wang, X., Wang, Y., MacIntyre, R., & Shi, X. (2020). Aerosol transmission of SARS-CoV-2? Evidence, prevention and control. Environment International, 144, 106039.
   PubMed Web of Science ®Google Scholar
• Tarique, M., Ahmad, S., Malik, A., Ahmad, I., Saeed, M., Almatroudi, A., Qadah, T., Murad, M. A., Mashraqi, M., Alam, Q., & Al-Saleh, Y. (2021). Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and other coronaviruses: a genome-wide comparative annotation and analysis. Molecular and Cellular Biochemistry, 476(5), 2203–2217.
   PubMed Web of Science ®Google Scholar
• User, M. (2018). Schrödinger Release 2019-3: Glide. Schrödinger, LLC. Schrödinger Release, 3.
   Google Scholar
• Usichenko, T. I., Foellner, S., Gruendling, M., Feyerherd, F., Lehmann, C., Wendt, M., & Pavlovic, D. (2006). Akrinor-induced relaxation of pig coronary artery in vitro is transformed into α1-adrenoreceptor-mediated contraction by pretreatment with propranolol. Journal of Cardiovascular Pharmacology, 47(3), 450–455.
   PubMed Web of Science ®Google Scholar
• Walters, W. P. (2012). Going further than Lipinski’s rule in drug design. Expert Opinion on Drug Discovery, 7(2), 99–107. https://doi.org/10.1517/17460441.2012.648612
   PubMed Web of Science ®Google Scholar
• Wang, M., Li, M., Ren, R., Li, L., Chen, E.-Q., Li, W., & Ying, B. (2020). International expansion of a novel SARS-CoV-2 mutant. Journal of Virology, 94(12), e00567-00520. https://doi.org/10.1128/JVI.00567-20
   Web of Science ®Google Scholar
• Wishart, D., Feunang, Y., Guo, A., Lo, E., Marcu, A., Grant, J., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., … Wilson, M. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/10.1093/nar/gkx1037
   PubMed Web of Science ®Google Scholar
• Yadav, M. K., Ahmad, S., Raza, K., Kumar, S., Eswaran, M., & Pasha Km, M. (2021). Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–13.
   Web of Science ®Google Scholar
• Yang, Q., Zhou, Y., Ai, J., Ma, J., Cao, F., Cao, W., Zhang, W., Wang, S., Chen, W., Ma, X., Zhang, W., & Li, W. (2020). Collaborated effort against SARS‐CoV‐2 outbreak in China. Clinical and Translational Medicine, 10(1), 13–16.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Richards, A., Barrasa, M. I., Hughes, S. H., Young, R. A., & Jaenisch, R. (2021). Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proceedings of the National Academy of Sciences, 118(21) https://doi.org/10.1073/pnas.2105968118
   Google Scholar